Tart cherry and metabolic

What 2 graded rows on tart cherry agree on for metabolic, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Tart cherry page, with its PubMed record.

Your question

Supplement
Tart cherry Choose another

Tart cherry and metabolic

2 rows · 674 people

Split. 1 row found an improvement and 1 had mixed results.

Mixed
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.
  • Grade C× 2
Rows
2
Trials
2
At least: a review without a trial count
People
674
Pooled reviews may count some twice

What the rows share

From the rows

The best-graded row, grade C, is a meta-analysis of 392 people (2026) and found an improvement.

The rows run from 282 to 392 people, published from 2023 to 2026: 1 pooled review and 1 single study.

The rows

1 improved · 1 mixed
  1. Grade CSerum uric acid · Improved

    Meta-analysis · n 392 · 2026 · Adults in 4 randomized trials (8 comparisons)

    Varied across trials · Varied across trials

    Serum uric acid fell modestly versus control (SMD −0.22, 95% CI −0.43 to −0.01).

    Row on the Tart cherry page · PubMed 42242852 (opens PubMed)

  2. Grade CGout flares, urine pH and serum urate (add-on to urate-lowering therapy) · Mixed

    RCT · n 282 · 2023 · Men with gout and acidic urine starting febuxostat

    Not stated in the abstract · 12 weeks

    Urine pH and serum urate changed similarly with the tart cherry–citrate mixture, a citrate mixture and sodium bicarbonate. The tart cherry mixture and the citrate mixture both had fewer flares than bicarbonate; the tart cherry mixture had lower CRP and urine albumin-to-creatinine ratio than both.

    Row on the Tart cherry page · PubMed 37679816 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.